Contents
Academic literature on the topic 'YC 5604'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'YC 5604.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "YC 5604"
Lin, Meng-Lung, and Cheng-Wu Chen. "RETRACTED: Stability analysis of community and ecosystem hierarchies using the Lyapunov method." Journal of Vibration and Control 17, no. 13 (December 9, 2010): 1930–37. http://dx.doi.org/10.1177/1077546310385737.
Full textChen, Cheng-Wu, Ken Yeh, Kevin FR Liu, and Meng-Lung Lin. "RETRACTED: Applications of fuzzy control to nonlinear time-delay systems using the linear matrix inequality fuzzy Lyapunov method." Journal of Vibration and Control 18, no. 10 (October 18, 2011): 1561–74. http://dx.doi.org/10.1177/1077546311410765.
Full textDissertations / Theses on the topic "YC 5604"
Schüle, Jana Marit. "Depressivität bei Patienten mit chronischer Hepatitis C vor und während der Behandlung mit Alpha-Interferon und Ribavirin." Doctoral thesis, Humboldt-Universität zu Berlin, Medizinische Fakultät - Universitätsklinikum Charité, 2005. http://dx.doi.org/10.18452/15336.
Full textInterferon-alpha (alpha-IFN) is presently the mainstay of the treatment of chronic hepatitis C. Side effects include a range of psychiatric symptoms, most frequently the development of depressive symptoms. Their incidence, severity and necessity for therapeutic intervention has not yet been sufficiently studied. 66 patients with chronic hepatitis C were enrolled in a pilot study and treated with either alpha-IFN alone (3x3 MU/ week) or in combination with Ribavirin (1000-1200 mg/ week). All patients went through repeated evaluations concerning their depressive symptoms before, during, and after treatment. Apart from individual interviews with the psychosomatic staff, the psychometric instruments used were the ADS (Allgemeine Depressions Skala, the German version of the Center for Epidemiological Studies Depression Scale, CES-D) and the BDI (Beck Depression Inventory). The initial depression score of the hepatitis C patients was comparable to that of a healthy population. On average, depression scores increased by 5,15 points (+/-8,94) on the ADS and 3,85 points (+/-6,94) on the BDI during the first 3 months of treatment. Less than a third of all patients did not show an increase of depressive symptoms. Patients with an initially low depression score experienced a greater increase of depressive symptoms than patients initially diagnosed as depressive. Nevertheless, the latter patients remained more depressive throughout the study period. Four patients developed severe depressions that necessitated admission to a psychiatric clinic. There was no significant correlation between the initial depression score and the treatment response. In order to recognize those patients at high risk for the development of severe depressions at an early stage, the author proposes the use of ADS and BDI both before and during treatment with alpha-IFN. Using a cut-off score of more than 17 points on the ADS before, and >=30 points during treatment, 75% of all patients developing severe depressions during treatment with alpha-IFN could be identified.
Alemayehu, Amare Eshetu. "Analysis of HCV Coinfections among Newly Diagnosed HIV Cases in Germany." Doctoral thesis, Humboldt-Universität zu Berlin, 2021. http://dx.doi.org/10.18452/22502.
Full textIn light of the major shift in HCV therapy resulting from the availability of highly potent direct acting antivirals (DAA), this study performed a surveillance of HCV coinfections among reported HIV new diagnoses in Germany. First the suitability of two HCV Ag/Ab ELISAs, Murex (Abbott) and Monolisa (Bio-Rad) for dried serum spots (DSS) was compared. The Murex was more sensitive in antigen positive plasma HCV seroconversion samples while the Monolisa showed a higher sensitivity in HCV antibody positive DSS eluates. Furthermore, an avidity test was established to distinguish between new and already longer existing infections at an avidity index cut-off of 40% and a period of 364 days. Of the total of 6,097 samples examined for the years 2015-2017, 396 were HCV ELISA reactive (6.5%). Of these, 256 (64.6%) were identified as active and 140 (35.4%) as resolved infections. A high proportion of HCV coinfections were observed in intravenous drug users (77.8%, n=168/216), in the age group 30-39 years (9%, n=179/1,978) and in people of Eastern European origin (38.3%, n=124/324). Compared to 2016, the proportion of resolved infections in 2017 has increased in the total number of patients (p<0.01) and especially in people of foreign (p<0.01) and Eastern European (p<0.05) origin. HCV subtypes (St)-1a, St-3a, and St-1b were predominant with 33.9% (n=79/233), 33.5% (n=78/233) and 23.3% (n=52/233), respectively. The proportion of St-1a and St-1b samples whose HCV sequence has resistance to DAAs was high in all diagnoses years (25%-42.9%). The observed increase in the proportion of resolved HCV coinfections can be attributed to DAA therapy. However, further efforts are needed to ensure that groups with continued high HCV prevalence benefit from this treatment.
Malkowski, Beate. "Charakterisierung funktioneller und struktureller Voraussetzungen der Hepatitis-B-Virus-Replikation." Doctoral thesis, Humboldt-Universität zu Berlin, Mathematisch-Naturwissenschaftliche Fakultät I, 2005. http://dx.doi.org/10.18452/15206.
Full textAssembly of HBV particles and subsequent secretion of mature virus requires the interaction of the nucleocapsid with defined domains of the surface proteins. Overlapping synthetic peptides covering the C-terminal part of the PreS1 domain and the cell permeable domain of PreS2 (TLM) were shown to localize most of all in the nucleus. Based on these peptides aa 101-115 of PreS1 were found to be essential for the interaction with the nucleocapsid, while the PreS2 domain does not interact with the nucleus. Presence of the peptides that compete the nucleocapsid surface protein interaction a block of HBV and antigen secretion was achieved. HBcAg as natural interaction partner of the surface proteins then arises increased in the nucleus. Recombinant proteins similar to the synthetic peptides but with the whole PreS2 domain localize in the cytoplasm and block HBV and antigen secretion. The genome of HBV encodes two transcriptional activators: the HBx protein and the PreS2 activator LHBs. Both trigger activation of c-Raf-1/MEK kinase cascade. To evaluate the importance of both activators for viral replication selective inhibitions of signal transduction cascades were performed and do not result in a decrease of viral replication. Simultaneous inhibition of both activators abolished viral secretion. It is due to a reduced de novo synthesis and not to an accumulation of viral proteins in cells. The relevance of activator function was tested by mutated HBV genome defective for HBx and / or PreS2 activator function. After transfection single mutants show no significant reduced HBV expression whereas at the double mutated HBV genome a strong reduced virus expression could be observed. The HBx protein and the PreS2 activator LHBs are important for viral replication but they can replace each other.
Roske, Yvette. "Kristallstrukturanalyse des kohlenhydratbindenden Moduls 27-1 der Beta-Mannanase 26 aus Caldicellulosiruptor saccharolyticus im Komplex mit Mannohexaose und Kristallisation der ATPase HP0525 aus Helicobacter pylori." Doctoral thesis, Humboldt-Universität zu Berlin, Medizinische Fakultät - Universitätsklinikum Charité, 2005. http://dx.doi.org/10.18452/15284.
Full textCarbohydrate-binding modules (CBMs) are the most common non-catalytic modules associated with enzymes active in plant cell-wall hydrolysis. Caldicellulosiruptor saccharolyticus strain Rt8B.4 Man26 is a thermostable modular glycoside hydrolase beta-mannanase which contains two non-catalytic modules in tandem at its N-terminus. These modules were recently shown to function primarily as ß-mannan-binding modules and have accordingly been classified as members of a novel family of CBMs, family 27. In the first part of this study, the crystallization and crystal structure analysis of the first carbohydrate binding module (CsCBM27-1) of the beta-mannanase from C. saccharolyticus in native and mannohexaose-bound form is described. The basis for this study were data from isothermal titration calorimetry for quantifying the binding affinity of CsCBM27-1 for soluble mannooligosaccharidesBoth structures permit further insights into the interaction of beta-mannan binding CBMs with their corresponding ligands. CsCBM27-1 shows the typical beta-sandwich jellyroll fold observed in other CBMs with a single calcium ion bound opposite to the ligand binding site. This arrangement is similar to topologies of other CBM families. The crystal structures reveal that the overall fold of CsCBM27-1 remains virtually unchanged upon sugar binding and that binding is mediated by three solvent-exposed tryptophan residues and few direct hydrogen bonds. The second part of this study addressed the purification and crystallization of the VirB11 ATPase HP0525 of Helicobacter pylori. The native HP0525 protein was produced in recombinant Escherichia coli and purified for crystallization. One of several crystallization experiments yielded large crystals by optimization of the concentration of the crystallization components. The crystals revealed good diffraction behavior. In addition to the native protein, selenomethionine-substituted HP0525 was produced and purified. Hexagonal crystals were obtained from the SeMet-HP0525. No derivative datasets were collected, because the crystal structure of the hexameric ATPase HP0525 was published by Yeo et al. (2000). Further structural investigations for the protein HP0525 were judged unnecessary.
Gebhardt, Deborah Patricia. "Verbesserung des Ernährungszustands bei Patienten mit Leberzirrhose nach Implantation eines transjugulären intrahepatischen portosystemischen Stent-Shunts (TIPS)." Doctoral thesis, Humboldt-Universität zu Berlin, Medizinische Fakultät - Universitätsklinikum Charité, 2000. http://dx.doi.org/10.18452/14622.
Full text22 patients with liver cirrhosis were examined prospectively regarding their nutritional state and its components energy expenditure, energy intake and body composition before and 1, 6 and 12 months after implantation of a transjugular intrahepatic portosystemic stent - shunt (TIPS). These data were compared to those corresponding of a group of healthy control subjects. Compared to these healthy individuals body weigth and body mass index (BMI) of the patients were not reduced while muscle mass and body cell mass (BCM) were impaired before TIPS-implantation. There was no difference in resting energy expenditure (REE) between both groups. The ratio REE/BCM is called specific resting energy expenditure. This ratio was found to be increased in the patient group which means that patients were hypermetabolic when compared to controls. Lipids turned out to be the prefered fuel in patients. After TIPS-insertion body weight and BMI increased in patients because muscle mass, BCM and BCM/body weight all increased significantly in the patient group. Meanwhile the amount of ascites was reduced significantly. Fat mass remained stable after TIPS. Because of this increase of body weight energy expenditure had to increase, too. On the contrary, the specific REE showed a decrease which means normalization of the pathological high results of this parameter. A decrease in specific REE and an increase in energiy intake lead to an improvement of energy balance. This is probably one min cause of the improvement in the nutritional state of the patients after TIPS. After TIPS lipids remained to be the main source of substrate for oxidation. Partly, the synthetical function of the liver was impaired after TIPS (thromboplastin time, but not Albumin) while renal function and mental performance measured by psychometric tests improved significantly. The implantation of TIPS and surveillance of its function in patients with liver cirrhosis was accompanied by an improvement of their nutritional state. Even more important, there was an improvement of body cell mass and of muscle mass which both are of significantly prognostic value in this kind of patients. Dietary recommendations were not changed after TIPS but patients were able to realize them in a better way and they tolerated an increased intake of protein without an increase in the rate of hepatic encephalopathy. Furthe studies will have to be performed in order to find out the influences of different factors as reduced amount of ascites, improvement of intestinal absorption or avoiding of catabolic periods (gastrointestinal bleeding, paracentesis and endotoxinaemia by reduction of portal hypertension).
Berg, Thomas. "Chronische Hepatitis C." Doctoral thesis, Humboldt-Universität zu Berlin, Medizinische Fakultät - Universitätsklinikum Charité, 2002. http://dx.doi.org/10.18452/13812.
Full textThe major goal of this thesis is the analysis of the clinical outcome of patients with Hepatitis C virus (HCV) infection and the response to therapy. Analysed were 1. different types of therapeutic strategies 2. causes responsible for ineffective antiviral therapy (non-response) 3. clinical relevance of the newly discovered hepatitis-associated viruses and 4. the role of these viruses in patients with acute or chronic hepatitis of unknown causes and in those receiving liver grafts. Ad 1. Compared were different therapeutic concepts such as short-term combination therapy, triple-therapy, high dose IFN?-therapy and the use of antiviral substances such as ribavirin and amantadine. It emerged that relevant prognostic parameters can be deduced with respect to the therapeutic response rate. Ad 2. Analysed were possible molecular mechanisms, which may interfere with response or non-response to antiviral therapy. In this respect, we focussed on the interaction of certain HCV-proteins as NS5A, E2, so-called PKR-eIF2a phosphorylisation-homology-domain (PePHD). with the interferon-?-induced effector proteins. There is evidence, that number of mutations within the NS5A proteins are of prognostic relevance with respect to the response to interferon?-therapy. In contrast, mutations within the PePHD-region do not play any role in this respect. Ad 3. We also studied the clinical relevance of the newly discovered viruses GBV-C/HGV and TTV, and found, that they have no impact concerning the course of chronic hepatitis C. These viruses are interferon-sensitive and do not influence the IFNa-response as it could be documented by following the course of co-infected patients. Ad 4. Our studies also focused on the prevalence, transmission and relevance of GBV-C/HGV and TTV infections with respect to their role as hepatitis-inducing agents. We can show that both virus types are parenterally transmitted. There is a high prevalence for both types in patients confronted with risk factors for parenteral factors. From analysis of many patients being chronically infected with these viruses it became quite clear that they lack any important potency to provoke chronic liver disease.